Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimegepant Dose-Ranging Study for Acute Migraine
NCT01430442Phase 2Completed
- Sponsor
- Pfizer
- Start
- Oct 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rimegepant in migraine, sponsored by Pfizer. Started Oct 2011; status: completed.
02
Drugs
rimegepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01430442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01430442.